Journal article icon

Journal article

Cerebrospinal fluid β-amyloid 42 and tau proteins as biomarkers of Alzheimer-type pathologic changes in the brain

Abstract:

Background: There is a clear need to develop an objective diagnostic test for Alzheimer disease (AD). Changes in the levels of cerebrospinal fluid (CSF) tau protein and β-amyloid 42 (Aβ42) peptide in patients with AD have been well documented, but the relationship between these biomarkers and neuropathologic changes in the brain is not established.
Expand abstract
Publication status:
Published
Peer review status:
Peer reviewed

Actions


Access Document


Authors


More by this author
Institution:
University of Oxford
Division:
MSD
Department:
Clinical Neurosciences
Role:
Author
Publisher:
American Medical Association
Journal:
Archives of Neurology More from this journal
Volume:
66
Issue:
3
Pages:
382-389
Publication date:
2009-03-01
Acceptance date:
2008-06-23
DOI:
EISSN:
1538-3687
ISSN:
0003-9942
Pubs id:
pubs:579209
UUID:
uuid:a6f5647d-8c6f-4e8b-9705-803a615e88b2
Local pid:
pubs:579209
Source identifiers:
579209
Deposit date:
2015-12-09

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP